Find your path to Benoit
192 people in our graph share verified history with Benoit — schools, employers, funds. One of them is your warm intro.
Micah RosenbloomunlockedBenoit: together at Harvard Business School (2002)
×10Benoit: together at Harvard Business School
Benoit: together at Puilaetco Dewaay Private Bankers
About
Benoit P. Bouche joined Ampersand as an Operating Partner in 2022 and chairs the board of P95. His career spans nearly 40 years in healthcare businesses as an entrepreneur, investor, advisor, and board member, with a focus on the pharmaceutical outsourcing industry. He was previously President and CEO of Nexelis, an immunology-focused lab and former Ampersand portfolio company acquired by IQVIA, and holds a PharmD (1984) and a Ph.D. in Pharmaceutical Sciences/Biotechnology (1986), along with completion of Harvard Business School's Advanced Management Program (2002).
Invests in
BiotechHealthtech
Experience
- Ampersand Capital PartnersOperating Partnercurrent2022 — presentBoston, Massachusetts, United States
- P95Chairman of the Boardcurrent2023 — presentLeuven, Flemish Region, Belgium
- ProtaGeneChairman of the Board2022 — 2024Dortmund, North Rhine-Westphalia, Germany
- ProtaGeneBoard Member2021 — 2022Germany
- NexelisPresident and CEO2017 — 2022Montreal, Canada Area
- Ampligen Consultancy HealthcareSenior Advisor1998 — 2018Brussels, Belgium
- MAPI GROUPBoard member1999 — 2017Lyon Area, France
- Galien DeveloppementChief Executive Officer, Founder2008 — 2012Aix en Provence, France
- Puilaetco Dewaay Private BankersExecutive Director, Head of Research, Head of Life Sciences1998 — 2002Brussels, Belgium
- FDM PharmaChief Executive Officer1993 — 1998Sophia Antipolis, France
- Forcing SAManaging Director, consulting1991 — 1993Sophia Antipolis
- Forcing Marketing ResearchConsultant1987 — 1991Lille
- ASTEL LaboratoiresRegistered Pharmacist1986 — 1990Lambersart, France
Skills & more
Healthcare6Growth Management1Innovation Management1Healthcare Banking1Biotechnology8Investment Banking6Medical TechnologyPrivate Equity3Valuation1Corporate Finance10Capital Markets2Mergers4
+10 more
Health SystemsEquitiesInvestmentsDue DiligenceVenture CapitalFinancial AnalysisBusiness StrategyManagement ConsultingLeadershipStrategyLanguages English
- FSA Accreditation BDB01025
From Benoit's professional profile.
Investments
Board seats
P95
Per the firm's website.
Colleagues at Ampersand
Aditya V. Goel
Associate at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
David Q. Anderson
General Partner at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand
Frank R. Witney
Operating Partner at Ampersand
Frequently asked questions
- Who is Benoit P. Bouche?
- Benoit P. Bouche joined Ampersand as an Operating Partner in 2022 and chairs the board of P95. His career spans nearly 40 years in healthcare businesses as an entrepreneur, investor, advisor, and board member, with a focus on the pharmaceutical outsourcing industry. He was previously President and CEO of Nexelis, an immunology-focused lab and former Ampersand portfolio company acquired by IQVIA, and holds a PharmD (1984) and a Ph.D. in Pharmaceutical Sciences/Biotechnology (1986), along with completion of Harvard Business School's Advanced Management Program (2002).
- Where does Benoit P. Bouche work?
- Benoit P. Bouche is Operating Partner at Ampersand.
- What does Benoit P. Bouche invest in?
- Benoit P. Bouche invests in Biotech, Healthtech.
- What boards does Benoit P. Bouche sit on?
- Benoit P. Bouche holds tracked board seats at P95.
- Where did Benoit P. Bouche go to school?
- Benoit P. Bouche studied at Harvard Business School (AMP - Advanced Management Program, Business Management Entrepreneurship); Université de Lille II (Pharm D - Doctorat en Pharmacie, Pharmacy).
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,994 more
